Guardant Health (GH) Tops Q1 EPS by 28c

Guardant Health (NASDAQ: GH) reported Q1 EPS of ($1.06), $0.28 better than the analyst estimate of ($1.34). Revenue for the quarter came in at $128.7 million versus the consensus estimate of $117.88 million.

GUIDANCE:

Guardant Health sees FY2023 revenue of $535-545 million, versus the consensus of $533 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Evolv Technology (EVLV) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
• TON Strategy Company (TONX) Tops Q2 EPS by 264c
• Vinci Partners Investments Ltd. (VINP) Misses Q2 EPS by 22c